Actos Lawsuit for Bladder Cancer

Actos is a prescription diabetes drug marketed by Takeda Pharmaceuticals. Actos is used to treat type-II diabetes, the more common form of diabetes found in the United States. Recently, sales of rival diabetes drug Avandia have declined sharply following detrimental reports of various health risks associated with the drug. These announcements have helped Actos sales soar and become the number one selling diabetes drug in the United States. Actos sales have risen dramatically mostly because people have perceived Actos to be the safer of the options.

Recently, however, a Actod medical study has been published by the FDA stating that there may also be significant health risks associated with taking Actos for diabetes. The FDA published results at the midpoint of an ongoing 10-year study of Actos which claim that Actos may cause an increased risk of developing bladder cancer. If you or a loved one have taken Actos and have been diagnosed with bladder cancer, you might have a case for an Actos bladder cancer lawsuit. We suggest you contact our law firm to discuss your options regarding an Actos lawsuit if you or a loved one took Actos and were later diagnosed with bladder cancer.

The results of the FDA's ongoing study claim that there is a significantly elevated risk of bladder cancer for patients taking Actos for more than a year. The report also says that there may be an increased risk of bladder cancer for those who have taken higher dosages of Actos. The FDA's report also claims that there is no overall increase in the risk of bladder cancer associated with taking Actos. This claim is disputed by a recent Actos Bladder cancer study in France.

The French Actos Study claims that there is in fact an overall increase in the risk of bladder cancer when taking Actos for diabetes. The French report also says that there is likely an increased risk of bladder cancer when taking Actos for a prolonged period of time at a higher dosage. These reports have caused officials in both France and Germany to remove Actos from the market. At this time, the FDA has not taken action to remove Actos from the US market. No Actos recall has been discussed by the FDA. The FDA has required Takeda to implement specific bladder cancer warnings on the Actos drug label.

Actos Lawsuit - Bladder Cancer

If you or a family member took Takeda Pharmaceutical's drug Actos (pioglitazone) and you have developed bladder cancer, we encourage you to contact a pharmaceutical lawyer at our firm immediately and discuss your rights to filing a Actos Lawsuit. An experienced pharmaceutical products liability lawyer at the Willis Law Firm can assist you in legal action in a potential Actos bladder cancer lawsuit against the makers of the drug.

Please fill out our online Actos Lawsuit evaluation form below or call us and we will contact you within 4-12 hours for a free confidential case review. Contact our law firm immediately so that we may explain the rights and options available to you and your family. Call 1-800-468-4878 for more Actos Lawsuit information.

Actos Lawsuit Help - Free Actos Bladder Cancer Lawsuit Evaluation